title: Reply to: letter to the editor "subcutaneous herceptin therapy".
authors.affiliation: Christchurch Clinical Studies, Christchurch, New Zealand.
authors.forename: Chris
authors.initials: C
authors.lastname: Wynne
authors.forename: Vernon
authors.initials: V
authors.lastname: Harvey
authors.forename: Christian
authors.initials: C
authors.lastname: Schwabe
authors.forename: Devonie
authors.initials: D
authors.lastname: Waaka
authors.forename: Christine
authors.initials: C
authors.lastname: McIntyre
authors.forename: Beate
authors.initials: B
authors.lastname: Bittner
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents